Corneal Sensitivity and Tear Function in Neurodegenerative Diseases

REFERENCES

• Checkoway H, Lundin JI, Kelada SN. Neurodegenerative diseases. IARC Sci Publ 2011;163:407–419
   Google Scholar
• Armstrong RA. Visual signs and symptoms of Parkinson's disease. Clin Exp Optom 2008;91:129–138
   PubMed Web of Science ®Google Scholar
• Ceccaldi M. Vision in Alzheimer's disease. Rev Neurol (Paris) 1996;152:441–446
   Google Scholar
• Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 2011;31:362–373
   PubMed Web of Science ®Google Scholar
• Fortuna F, Barboni P, Liguori R, Valentino ML, Savini G, Gellera C, et al. Visual system involvement in patients with Friedreich's ataxia. Brain 2009;132:116–123
   PubMed Web of Science ®Google Scholar
• Muranaka H, Fujita H, Goto A, Osari SI, Kimura Y. Visual symptoms in epilepsy and migraine: localization and patterns. Epilepsia 2001;42:62–66
   Google Scholar
• Pelak VS, Hall DA. Neuro-ophthalmic manifestations of neurodegenerative disease. Ophthalmol Clin North Am 2004;17:311–320
   PubMedGoogle Scholar
• Katz B, Rimmer S. Ophthalmologic manifestations of Alzheimer's disease. Surv Ophthalmol 1989;34:31–43
   Web of Science ®Google Scholar
• Wolin MJ. Alzheimer's disease and the eye. J S C Med Assoc 1994;90:534–538
   PubMedGoogle Scholar
• Baker DR, Mendez MF, Townsend JC, Ilsen PF, Bright DC. Optometric management of patients with Alzheimer's disease. J Am Optom Assoc 1997;68:483–494
   PubMedGoogle Scholar
• Woodruff-Pak DS, Papka M, Romano S, Li YT. Eyeblink classical conditioning in Alzheimer's disease and cerebrovascular dementia. Neurobiol Aging 1996;17:505–512
   Google Scholar
• Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol 2005;16:315–320
   PubMedGoogle Scholar
• Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord 2011;26:2387–2395
   PubMed Web of Science ®Google Scholar
• Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX. Ocular motor and sensory function in Parkinson's disease. Ophthalmology 2012;119:178–182
   PubMed Web of Science ®Google Scholar
• Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 2011;17:431–436
   Google Scholar
• Noval S, Contreras I, Sanz-Gallego I, Manrique RK, Arpa J. Ophthalmic features of Friedreich ataxia. Eye (Lond) 2012;26:315–320
   PubMed Web of Science ®Google Scholar
• Hocking DR, Fielding J, Corben LA, Cremer PD, Millist L, White OB, et al. Ocular motor fixation deficits in Friedreich ataxia. Cerebellum 2010;9:411–418
   Google Scholar
• Abe T, Abe K, Aoki M, Itoyama Y, Tamai M. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch Ophthalmol 1997;115:231–236
   PubMedGoogle Scholar
• Bajwa R, Jay WM, Asconapé J. Neuro-ophthalmologic manifestations of epilepsy. Semin Ophthalmol 2006;21:255–261
   PubMedGoogle Scholar
• Reddy VC, Patel SV, Hodge DO, Leavitt JA. Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease. Cornea 2013;32:631–635
   PubMed Web of Science ®Google Scholar
• Tamer C, Melek IM, Duman T, Oksüz H. Tear film tests in Parkinson's disease patients. Ophthalmology 2005;112:1795
   PubMed Web of Science ®Google Scholar
• Kwon OY, Kim SH, Kim JH, Kim MH, Ko MK. Schirmer test in Parkinson's disease. J Korean Med Sci 1994;9:239–242
   Google Scholar
• Miró J, Peña-Sagredo JL, Berciano J, Insúa S, Leno C, Velarde R. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol 1990;27:582–584
   Google Scholar
• Coyle PK, Sibony PA. Tear analysis in multiple sclerosis. Neurology 1986;36:547–550
   Web of Science ®Google Scholar
• Annunziata P, De Santi L, Di Rezze S, Millefiorini E, Capello E, Mancardi G, et al. Clinical features of Sjogren's syndrome in patients with multiple sclerosis. Acta Neurol Scand 2011;124:109–114
   Google Scholar
• Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65–74
   PubMed Web of Science ®Google Scholar
• Wakamatsu TH, Dogru M, Tsubota K. Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol 2008;71:72–79
   PubMed Web of Science ®Google Scholar
• Bourcier T, Acosta MC, Borderie V, Borrás F, Gallar J, Bury T, et al. Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci 2005;46:2341–2345
   PubMed Web of Science ®Google Scholar
• Benítez-Del-Castillo JM, Acosta MC, Wassfi MA, Díaz-Valle D, Gegúndez JA, Fernandez C, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci 2007;48:173–181
   PubMed Web of Science ®Google Scholar
• Matsui H, Kumano Y, Zushi I, Yamada T, Matsui T, Nishida T. Corneal sensation after correction of myopia by photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg 2001;27:370–373
   PubMed Web of Science ®Google Scholar
• Kumano Y, Matsui H, Zushi I, Mawatari A, Matsui T, Nishida T, et al. Recovery of corneal sensation after myopic correction by laser in situ keratomileusis with a nasal or superior hinge. J Cataract Refract Surg 2003;29:757–761
   PubMed Web of Science ®Google Scholar
• Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584–589
   PubMed Web of Science ®Google Scholar
• Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004;78:409–416
   PubMed Web of Science ®Google Scholar
• Kahana E, Leibowitz U, Alter M. Brainstem and cranial nerve involvement in multiple sclerosis. Acta Neurol Scand 1973;49:269–279
   PubMed Web of Science ®Google Scholar
• Zadro I, Barun B, Habek M, Brinar VV. Isolated cranial nerve palsies in multiple sclerosis. Clin Neurol Neurosurg 2008;110:886–888
   PubMedGoogle Scholar
• Palakuru JR, Wang J, Aquavella JV. Effect of blinking on tear dynamics. Invest Ophthalmol Vis Sci 2007;48:3032–3037
   PubMed Web of Science ®Google Scholar
• Fisher A. Muscarinic receptor agonists in Alzheimer's disease. CNS Drugs 1999;12:197–214
   Web of Science ®Google Scholar
• Gunal DI, Afsar N, Tanridag T, Aktan S. Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. Eur Neurol 2002;48:1–5
   PubMed Web of Science ®Google Scholar
• Chakravarty K, al-Jafari MS. Phenytoin-induced pseudo-Sjögren's syndrome. Br J Rheumatol 1996;35:1033–1034
   Google Scholar
• Marino D, Malandrini A, Rocchi R, Selvi E, Federico A. Transient “sicca syndrome” during phenobarbital treatment. J Neurol Sci 2011;15:164
   Google Scholar
• Ingall TJ, McLeod JG. Autonomic function in Friedreich's ataxia. J Neurol Neurosurg Psychiatry 1991;54:162–164
   Google Scholar
• Fraunfelder FT, Sciubba JJ, Mathers WD. The role of medications in causing dry eye. J Ophthalmol 2012;2012:1--8
   Google Scholar
• Murphy PJ, Lawrenson JG, Patel S, Marshall J. Reliability of the noncontact corneal aesthesiometer and its comparison with the Cochete Bonnet aesthesiometer. Ophthal Physiol Opt 1998;18:e532–e539
   PubMed Web of Science ®Google Scholar